Key facts
- This page summarizes Ivor Elrifi's Form 4 filing for Tiziana Life Sciences Ltd (TLSA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Aug 2026, 09:30.
Ivor Elrifi - 04 Aug 2026 Form 4 Insider Report for Tiziana Life Sciences Ltd (TLSA)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- TLSA
- Reported as of
- 04 Aug 2026
- Net transaction value
- +$318,909
- SEC form
- 4
- Accepted by SEC
- 06 Aug 2026, 09:30:02 UTC
- Prior SEC filing
- 05 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ivor Elrifi
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ivor Elrifi filed Form 4 for Tiziana Life Sciences Ltd (TLSA) on 06 Aug 2026.
Change
- Previous filing in this sequence was filed on 05 Aug 2026.
- Current net transaction value: +$318,909.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002136241
Primary reporting owner
Elrifi Ivor
- Relationship
- Chief Executive Officer
- Address
- 535 BOYLSTON STREET, BOSTON
- Signature
- /s/ Ivor Elrifi
- Signature date
- 06 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSA
transaction
COMMON STOCK
Purchase
- Transaction value
- $81,293
- Shares
- +83,807
- Change %
- +1.9%
- Price
- $0.9700
- Shares after
- 4,556,068
- Date
- 04 Aug 2026
- Ownership
- By trust
TLSA
transaction
COMMON STOCK
Purchase
- Transaction value
- $237,616
- Shares
- +237,616
- Change %
- +5.2%
- Price
- $1.00
- Shares after
- 4,793,684
- Date
- 05 Aug 2026
- Ownership
- By trust
* marks a reported price that did not pass the local price check.